Tyndal Labs

Visakhapatnam, India Founded: 1956 • Age: 70 yrs
Focuses on research, development, and manufacturing of pharmaceutical APIs and intermediates worldwide.

About Tyndal Labs

Tyndal Labs is a Healthcare company based in Visakhapatnam (India) founded in 1956. It focuses on research, development, and manufacturing of pharmaceutical APIs and intermediates worldwide. It operates on a B2B model. The company has 1 employees. Its Indian entity Tyndal Labs Private Limited reported revenue of β‚Ή9.69 Cr. Tyndal Labs offers products and services including API's, Oncology Intermediates, and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing, Intermediates and Oncology. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Tyndal Labs Private Limited, established in 2020, specializes in research and development of complex pharmaceutical products under regulatory standards. They develop items at lab scale using various techniques and transfer technology to organizations globally. The company provides contract manufacturing in GMP-compliant plants, emphasizing cost-effective and eco-friendly processes. Located in Visakhapatnam, India, they serve esteemed clients in the pharmaceutical industry through innovative solutions.

  • Headquarters Visakhapatnam, India
  • Employees 1
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website tyndallabs.com
  • Social LinkedIn Facebook Instagram
  • Legal Name Tyndal Labs Private Limited
  • Date of Incorporation 23 May, 2020
  • Jurisdiction Paravada, Andhra Pradesh, India
Key Metrics
  • Annual Revenue
    ₹9.69 Cr

    FY 2024 · -58% YoY

  • Net Profit
    ₹14.9 Lakh

    FY 2024 · 2% margin

  • EBITDA
    ₹30.7 Lakh

    FY 2024 · 3% margin

  • Employee Count
    1

Products & Services of Tyndal Labs

Tyndal Labs offers a comprehensive portfolio of products and services, including API's, Oncology Intermediates, and Intermediates.

API's
Pharmaceutical Products

Development and manufacturing of advanced APIs for global pharmaceutical needs.

Oncology Intermediates
Chemical Intermediates

Specialized intermediates for oncology drug production and research.

Intermediates
Chemical Intermediates

General intermediates for various pharmaceutical applications and processes.

Board of directors of Tyndal Labs Private Limited (Tyndal Labs)

Tyndal Labs Private Limited is the primary company behind Tyndal Labs. The board of Tyndal Labs Private Limited currently have 2 directors; the longest-serving is Anusha Maddireddi, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Anusha Maddireddi
DIN 08739233
Director23 May 20206 yrs 5 moTyndal Labs Private Limited
Srinivasareddy Maddireddy
DIN 08297773
Director23 May 20206 yrs 5 moTyndal Labs Private Limited

Financials of Tyndal Labs

Figures of Tyndal Labs Private Limited, the primary company behind Tyndal Labs, for FY 2024. Revenue was ₹9.69 Cr (-58% year on year). Net profit was ₹14.9 Lakh (2% margin). EBITDA was ₹30.7 Lakh (3% margin). Revenue has grown at a compounded annual rate of +120% over three years.

  • ₹9.69 CrRevenue · FY 2024 · -58% YoY
  • ₹14.9 LakhNet profit · 2% margin
  • ₹30.7 LakhEBITDA · 3% margin
  • ₹1 LakhPaid-up capital
  • +120%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Tyndal Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Tyndal Labs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Tyndal Labs

Tyndal Labs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Tyndal Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Tyndal Labs

Tyndal Labs was founded in 1956.

Tyndal Labs is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.

Tyndal Labs has 1 employees.

The primary company behind Tyndal Labs, Tyndal Labs Private Limited, reported revenue of β‚Ή9.69 Cr for FY 2024, down 58% year on year.

Tyndal Labs Private Limited, established in 2020, specializes in research and development of complex pharmaceutical products under regulatory standards. They develop items at lab scale using various techniques and transfer technology to organizations globally. The company provides contract manufacturing in GMP-compliant plants, emphasizing cost-effective and eco-friendly processes. Located in Visakhapatnam, India, they serve esteemed clients in the pharmaceutical industry through innovative solutions.

Tyndal Labs's top competitors include Laurus Labs, Symbiotec and SeQuent.

Tyndal Labs offers API's, Oncology Intermediates, and Intermediates.

Tyndal Labs operates through Tyndal Labs Private Limited.

The legal entities of Tyndal Labs currently have 2 directors, including Anusha Maddireddi, Srinivasareddy Maddireddy.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available